Premium
A Phase I dose‐escalation study of DCLL9718S , an antibody‐drug conjugate targeting C ‐type lectin‐like molecule‐1 ( CLL ‐1) in patients with acute myeloid leukemia
Author(s) -
Daver Naval,
Salhotra Amandeep,
Brandwein Joseph M.,
Podoltsev Nikolai A.,
Pollyea Daniel A.,
Jurcic Joseph G.,
Assouline Sarit,
Yee Karen,
Li Mengsong,
Pourmohamad Tony,
Samineni Divya,
Sumiyoshi Teiko,
Vaze Anjali,
Dere Randall C.,
Ma Connie,
Cooper James
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26136
Subject(s) - antibody drug conjugate , cancer research , myeloid leukemia , antibody , myeloid , chemistry , monoclonal antibody , microbiology and biotechnology , immunology , medicine , biology